"NF-kappa B p52 Subunit" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A component of NF-kappa B transcription factor. It is proteolytically processed from NF-kappa B p100 precursor protein and is important for maturation of B-LYMPHOCYTES and adaptive HUMORAL IMMUNITY.
| Descriptor ID |
D052003
|
| MeSH Number(s) |
D12.776.157.687.497 D12.776.260.600.186 D12.776.660.600.186 D12.776.660.720.497 D12.776.930.600.186
|
| Concept/Terms |
NF-kappa B p52 Subunit- NF-kappa B p52 Subunit
- NF kappa B p52 Subunit
- NF-kappaB p52 Subunit
- NF kappaB p52 Subunit
- Transcription Factor H2TF1
- H2TF1, Transcription Factor
- NFKB2 Transcription Factor
- Transcription Factor, NFKB2
- NK-kappa B p52
- NK kappa B p52
- p52, NK-kappa B
- NF-kappaB p52
- NF kappaB p52
- NF-kappaB2
- NF kappaB2
|
Below are MeSH descriptors whose meaning is more general than "NF-kappa B p52 Subunit".
Below are MeSH descriptors whose meaning is more specific than "NF-kappa B p52 Subunit".
This graph shows the total number of publications written about "NF-kappa B p52 Subunit" by people in this website by year, and whether "NF-kappa B p52 Subunit" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "NF-kappa B p52 Subunit" by people in Profiles.
-
Autoantibodies against type I IFNs in humans with alternative NF-?B pathway deficiency. Nature. 2023 Nov; 623(7988):803-813.
-
NFKB2 haploinsufficiency identified via screening for IFN-a2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications. J Allergy Clin Immunol. 2023 04; 151(4):926-930.e2.
-
MKK4 activates non-canonical NF?B signaling by promoting NF?B2-p100 processing. Biochem Biophys Res Commun. 2017 09 16; 491(2):337-342.
-
Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth. Nat Commun. 2015 Oct 12; 6:8428.
-
Evaluation of NF-?B subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions. Mod Pathol. 2015 Sep; 28(9):1202-13.
-
T cell-intrinsic function of the noncanonical NF-?B pathway in the regulation of GM-CSF expression and experimental autoimmune encephalomyelitis pathogenesis. J Immunol. 2014 Jul 01; 193(1):422-30.
-
SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction. Cell Rep. 2012 May 31; 1(5):434-43.
-
The noncanonical NF-?B pathway. Immunol Rev. 2012 Mar; 246(1):125-40.
-
Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin. PLoS One. 2009 Sep 10; 4(9):e6992.
-
NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation. Prostate. 2008 Dec 01; 68(16):1725-33.